Sulphasalazine induced three-week syndrome.
Suresh
Resmy
R
Department of Rheumatology, Mayday University Hospital, Croydon, UK. resmy.suresh@mayday.nhs.uk
Gupta
Sanjay
S
Sathananthan
Rosh
R
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004487:Edema / Q000139:chemically induced* / Q000175:diagnosis; D005076:Exanthema / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D008206:Lymphatic Diseases / Q000139:chemically induced* / Q000175:diagnosis; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine